Leadership Overview
Cold Spring Harbor Laboratory has 7 executives leading key functions including research strategy, financial oversight, operational management, legal compliance, institutional advancement, and sponsored programs.
Dedicated to advancing biomedical discovery, Cold Spring Harbor Laboratory fosters a collaborative environment where scientists explore cancer, neuroscience, and plant biology to improve global health outcomes.
Dedicated to advancing biomedical discovery, Cold Spring Harbor Laboratory fosters a collaborative environment where scientists explore cancer, neuroscience, and plant biology to improve global health outcomes.
Leadership Roles at Cold Spring Harbor Laboratory
Bruce Stillman - President & Chief Executive Officer
Bruce Stillman, the President & Chief Executive Officer at Cold Spring Harbor Laboratory, directs the overarching scientific vision and research priorities for the institution. By aligning laboratory resources with critical breakthroughs in cancer and neuroscience, the President & Chief Executive Officer ensures the organization maintains a leading position in global biomedical research. This leadership role involves constant engagement with the Board to secure funding and promote academic excellence across all departments. Bruce Stillman actively shapes the long-term trajectory of the laboratory, fostering an environment where quantitative biology and plant biology research thrive. Through rigorous oversight of scientific programs, the President & Chief Executive Officer drives innovation that translates complex biological data into tangible medical advancements. By managing high-level institutional partnerships, Stillman secures the necessary support to sustain world-class research initiatives that impact the international scientific community.
Nicholas Milowski - Chief Financial Officer
Nicholas Milowski, the Chief Financial Officer at Cold Spring Harbor Laboratory, manages the fiscal health and long-term economic sustainability of the research institution. Overseeing complex budgetary allocations, the Chief Financial Officer ensures that capital flows efficiently toward high-impact cancer and neuroscience research projects. This role requires precise financial modeling to support the laboratory's non-profit mission while maintaining transparency with stakeholders. Nicholas Milowski directs the financial planning and analysis teams to optimize resource distribution across diverse scientific departments. By implementing robust fiscal controls, the Chief Financial Officer mitigates operational risks and maximizes the impact of research grants. Milowski maintains a focus on long-term financial stability, allowing the laboratory to pursue ambitious scientific goals without compromising fiscal integrity. Through strategic financial stewardship, the Chief Financial Officer enables the organization to sustain its commitment to education and discovery.
John Tuke - Chief Operating Officer
John Tuke, the Chief Operating Officer at Cold Spring Harbor Laboratory, manages the daily operational infrastructure required to support advanced biomedical research. Overseeing facility maintenance, laboratory logistics, and administrative support services, the Chief Operating Officer ensures that scientists possess the necessary environment to conduct complex experiments in plant biology and neuroscience. This role involves coordinating cross-departmental workflows to enhance efficiency and safety across the campus. John Tuke directs the implementation of operational policies that streamline research support, allowing the laboratory to maintain its status as a premier research institution. By optimizing internal processes, the Chief Operating Officer supports the broader mission of the organization. Tuke monitors operational performance metrics to identify areas for improvement, ensuring that the laboratory remains agile in a competitive scientific landscape. Through effective management of physical and human resources, the Chief Operating Officer facilitates groundbreaking discovery.
Morgan Browne - President
Morgan Browne, the President at Cold Spring Harbor Laboratory, directs the institutional growth and external engagement strategies that support the laboratory's research mission. Overseeing the expansion of educational programs and public outreach, the President ensures that the laboratory's findings in cancer and neuroscience reach a broad audience. This role involves cultivating relationships with donors and academic partners to secure the resources necessary for continued scientific innovation. Morgan Browne leads initiatives that enhance the visibility of the laboratory within the global scientific community. By focusing on institutional development, the President drives the growth of programs that bridge the gap between basic research and clinical application. Browne coordinates with other executive leaders to ensure that the laboratory's strategic goals remain aligned with its non-profit objectives. Through dynamic leadership, the President fosters a culture of excellence that attracts top-tier talent to the institution.
Charles Prizzi - Senior VP, Advancement & Special To The Advisor & President
Charles Prizzi, the Senior VP, Advancement & Special To The Advisor & President at Cold Spring Harbor Laboratory, directs the fundraising and institutional advancement strategies that fuel biomedical research. Overseeing donor relations and capital campaigns, the Senior VP, Advancement & Special To The Advisor & President ensures that the laboratory maintains the financial resources required for cutting-edge cancer and neuroscience studies. This role involves crafting compelling narratives that communicate the value of the laboratory's research to potential supporters. Charles Prizzi manages the advancement team to build long-term partnerships that sustain the institution's educational and research programs. By providing strategic advice to the President, the Senior VP, Advancement & Special To The Advisor & President helps shape the future direction of the laboratory. Prizzi monitors philanthropic trends to identify new opportunities for growth, ensuring that the organization remains well-positioned to achieve its scientific goals.
Debbie Arenare - Vice President, General Counsel
Debbie Arenare, the Vice President, General Counsel at Cold Spring Harbor Laboratory, manages all legal affairs, regulatory compliance, and intellectual property matters for the research institution. Overseeing the protection of scientific discoveries, the Vice President, General Counsel ensures that the laboratory adheres to strict ethical and legal standards in cancer and neuroscience research. This role involves negotiating complex research agreements and managing institutional risk to safeguard the reputation of the organization. Debbie Arenare directs the legal team to provide guidance on governance and policy, ensuring alignment with non-profit regulations. By navigating the intricate legal landscape of biomedical research, the Vice President, General Counsel enables the laboratory to collaborate effectively with academic and commercial partners. Arenare provides critical counsel to the executive leadership, ensuring that all strategic initiatives remain within legal boundaries. Through proactive risk management, the Vice President, General Counsel protects the integrity of the research mission.
Walter Goldschmidts - Vice President and Executive Director, Office of Sponsored Programs
Walter Goldschmidts, the Vice President and Executive Director, Office of Sponsored Programs at Cold Spring Harbor Laboratory, directs the acquisition and management of research grants from federal and private sources. Overseeing the proposal development process, the Vice President and Executive Director, Office of Sponsored Programs ensures that scientists receive the necessary funding to pursue research in cancer, neuroscience, and plant biology. This role involves navigating complex grant requirements and ensuring compliance with sponsor regulations. Walter Goldschmidts manages the administrative support for all sponsored projects, facilitating the submission of high-quality research applications. By optimizing the grant lifecycle, the Vice President and Executive Director, Office of Sponsored Programs enables the laboratory to maintain a robust portfolio of funded research. Goldschmidts collaborates with faculty to identify funding opportunities that align with the laboratory's strategic priorities. Through meticulous oversight, the Vice President and Executive Director, Office of Sponsored Programs supports the financial viability of the research enterprise.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership FB
AS
Charles River has delivered solutions to accelerate the development of drugs, chemicals, and medical devices for the people and patients who need them. Our products and services support clients from basic research, discovery, and safety assessment, to manufacturing and commercialization. With this expansive end-to-end portfolio, global capacity, and proven scientific and regulatory advisors, our integrated approach enables maximum speed and confidence on the drive to market.
Company Leadership
AC
MH
Founded in 1969, Bionetics Corporation is a company that offers environmental monitoring, readiness monitoring, and instrument calibration services. They are based in Yorktown, Virginia.
Company Leadership DT
HR
CH
KV
The Emmes Group is a global research and consulting organization specializing in scientific and clinical research, data management, and program evaluation. The company provides comprehensive services in the areas of public health, biomedical research, and life sciences, partnering with government agencies, non-profit organizations, and private sector clients. With expertise in research design, data analysis, and management consulting, The Emmes Group is dedicated to advancing evidence-based solutions that improve health outcomes and drive innovation in scientific research.
Company Leadership
JR
KM
Frequently Asked Questions Regarding Cold Spring Harbor Laboratory Top Executives and Leadership Team
